Literature DB >> 8675346

Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.

T R Kozel1, A Tabuni, B J Young, S M Levitz.   

Abstract

Previous studies demonstrated that, following opsonization with normal human serum (NHS), phagocytes bind greater numbers of small-capsule Cryptococcus neoformans cells than yeast cells with large capsules. The present study tested the hypothesis that suboptimal deposition of opsonic C3 fragments contributes to this disparity. C neoformans was grown under conditions promoting large or small capsules and was incubated at various concentrations in NHS. At low concentrations of yeast cells (125 cells per microl of NHS), the deposition of C3 fragments per unit of capsule volume and the binding of yeast cells to cultured human monocytes were similar for yeast cells having large and small capsules. However, at higher cell concentrations, large-capsule cells exhibited suboptimal coating with C3 fragments and markedly diminished monocyte binding compared with small-capsule cells. Thus, the inverse correlation between capsule size and phagocyte binding can be overcome by conditions promoting optimal C3 deposition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675346      PMCID: PMC174075          DOI: 10.1128/iai.64.6.2336-2338.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Complement depletion in cryptococcal sepsis.

Authors:  A M Macher; J E Bennett; J E Gadek; M M Frank
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

2.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

3.  Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.

Authors:  T R Kozel; R P Mastroianni
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

4.  Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes.

Authors:  S F Davies; D P Clifford; J R Hoidal; J E Repine
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

5.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

6.  Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans.

Authors:  S M Levitz; A Tabuni; H Kornfeld; C C Reardon; D T Golenbock
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.

Authors:  F J Swenson; T R Kozel
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

8.  Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.

Authors:  D L Granger; J R Perfect; D T Durack
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

9.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

10.  Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.

Authors:  F M Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

View more
  11 in total

1.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

Review 2.  Cryptococcus neoformans, a fungus under stress.

Authors:  Sarah M Brown; Leona T Campbell; Jennifer K Lodge
Journal:  Curr Opin Microbiol       Date:  2007-08-17       Impact factor: 7.934

Review 3.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

4.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.

Authors:  Dale Netski; Thomas R Kozel
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans.

Authors:  S S Mambula; E R Simons; R Hastey; M E Selsted; S M Levitz
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

8.  Spatiotemporal dynamics of complement C5a production within bacterial extracellular polymeric substance.

Authors:  Erin C Conrad; Yueh-Ya Hsu; David M Bortz; John G Younger
Journal:  J Innate Immun       Date:  2013-01-11       Impact factor: 7.349

Review 9.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

Review 10.  Fungal Strategies to Evade the Host Immune Recognition.

Authors:  Marco J Hernández-Chávez; Luis A Pérez-García; Gustavo A Niño-Vega; Héctor M Mora-Montes
Journal:  J Fungi (Basel)       Date:  2017-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.